Eli Lilly and Amylin Pharmaceuticals Inc. reported four new deaths in patients taking Byetta, even as the companies tried to shore up the safety profile of their diabetes medication. The disclosure comes a week after the Food and Drug Administration said two Byetta patients died of acute pancreatitis, sinking shares of both drug makers. An executive from Lilly said the FDA was aware of the additional deaths but did not reveal them because they involved a milder form of pancreatitis. The condition can cause nausea, vomiting, and abdominal pain. "They were concentrating on the more severe forms of the condition, but we felt it was important to get this information out there," said Eli Lilly medical director James Malone. Malone emphasized that all four patients had complicating medical conditions, which were probably the primary cause of death (AP)."
Did that sound like the damn piece was more worried about the stock price than the deaths?
That's what I thought!
And it was your own fault their poisons killed you, patients!
